After detailed deliberation, the committee recommended the approval of the protocol amendment as presented by the firm. Dr.

New Delhi: IQVIA has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control ...

Ischemic heart disease (IHD) remains the leading cause of mortality globally, despite advancements in pharmacotherapy and revascularization techniques that ...

Conducting clinical trials is undoubtedly complex, but the rewards are immeasurable for advancing healthcare and improving ...

Previously, all patients would be grouped together and treated using the same protocols, which has very mixed outcomes ... Recently, Dr Green led the development of new guidelines to improve how bone ...

Ongoing debates concern the best practices for deploying these technologies across varying clinical situations, emphasizing ...

In the rest of this section, we discuss recommendations that show how these TIC criteria can be adapted to the design of I/DD ...

Sun, Y. , Cheng, X. and Pen, K. (2024) Clinical Value of Platelet-Related Parameters and Monocyte Counts in Patients with ...

Dr Michelle Melisko discusses the challenging aspects involved in decision-making around screening for brain metastasis in ...

The following is a summary of “Triple Rule Out CT in the Emergency Department: Clinical Risk and Outcomes (Triple Rule Out in ...

Intensive follow-up testing in patients with stage II or III CRC following curative surgery does not appear to improve ...